Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Investigator-sponsored phase 1 trial data of breast cancer treatment presented
March 17th, 2005
NeoRx Corporation (NERX) announced the presentation of updated data from an investigator-sponsored phase 1 trial of STR, NeoRx's investigational bone-targeted radiotherapeutic, in patients with advanced breast cancer. The data were presented by Richard Champlin, MD, chair of the Department of Blood and Marrow Transplantation at MD Anderson Cancer Center, at the 2005 Tandem BMT Meetings in Keystone, Colorado. The Tandem BMT Meetings are the joint meeting of the American Society for Blood and Marrow Transplantation and the Center for International Blood and Marrow Transplant Research. The phase 1 dose-escalation study of STR involved 6 patients with...
Source: Women's Health Weekly (2005-03-17)
|
